Harihara Baskaran

Dr. Harihara Baskaran

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2011 in Nanotechnology
Verified
Journal Article
Open access
RTRandall Toy
Randall Toy
EHElliott Hayden
Elliott Hayden
CSChristopher Shoup
Christopher Shoup
HBHarihara Baskaran
Harihara Baskaran
EKEfstathios Karathanasis
Efstathios Karathanasis
In the recent past, remarkable advances in nanotechnology have generated nanoparticles of different shapes and sizes, which have been shown to exhibit unique properties suitable for biomedical applications such as cancer therapy and imaging. Obviously, all nanoparticles are not made equal. This becomes evident when we consider their transport behavior under blood flow in microcirculation. In this work, we evaluated the effect of critical physical characteristics such as the particle shape, size and density on a nanoparticle's tendency to marginate towards the vessel walls in microcirculation using an in vitro model. The wall deposition of nanoparticles was tested in a fibronectin-coated microfluidic channel at a physiologically relevant flow rate. Different classes of nanoparticles (liposome, metal particles) of different sizes (60-130 nm), densities (1-19 g ml(-1)) and shapes (sphere, rod) displayed significantly different deposition as a result of different margination rates. The smaller-sized and the oblate-shaped particles displayed a favorable behavior as indicated by their higher margination rates. Notably, the particle density showed an even more essential role, as it was observed that the lighter particles marginated significantly more. Since nanoparticles must escape the flow in order to approach the vascular bed and subsequently extravascular components for meaningful interactions, the design of nanoparticles strongly affects their margination, a key factor for their ultimate in vivo effectiveness.

2 August 2010 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
WLWan‐Hsiang Liang
Wan‐Hsiang Liang
BKBrian L. Kienitz
Brian L. Kienitz
KPKitsie J. Penick
Kitsie J. Penick
JWJean F. Welter
Jean F. Welter
TZThomas A. Zawodzinski
Thomas A. Zawodzinski
HBHarihara Baskaran
Harihara Baskaran

17 March 2009 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
VJVijay Janakiraman
Vijay Janakiraman
DEDerek Englert
Derek Englert
AJArul Jayaraman
Arul Jayaraman
HBHarihara Baskaran
Harihara Baskaran

1 September 2007 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
SSSohel Shaikh
Sohel Shaikh
ABAnil Birdi
Anil Birdi
SQSyed Qutubuddin
Syed Qutubuddin
ELEric Lakatosh
Eric Lakatosh
HBHarihara Baskaran
Harihara Baskaran

1 May 2013 in Tissue Engineering Part A
Verified
Journal Article
Closed access
CCChih-Ling Chou
Chih-Ling Chou
ARAlexander L. Rivera
Alexander L. Rivera
TSTakao Sakai
Takao Sakai
ACArnold I. Caplan
Arnold I. Caplan
VGVictor M. Goldberg
Victor M. Goldberg
HBHarihara Baskaran
Harihara Baskaran
Tissue engineering is a possible method for long-term repair of cartilage lesions, but current tissue-engineered cartilage constructs have inferior mechanical properties compared to native cartilage. This problem may be due to the lack of an oriented structure in the constructs at the microscale that is present in the native tissue. In this study, we utilize contact guidance to develop constructs with microscale architecture for improved chondrogenesis and function. Stable channels of varying microscale dimensions were formed in collagen-based and polydimethylsiloxane membranes via a combination of microfabrication and soft-lithography. Human mesenchymal stem cells (MSCs) were selectively seeded in these channels. The chondrogenic potential of MSCs seeded in these channels was investigated by culturing them for 3 weeks under differentiating conditions, and then evaluating the subsequent synthesized tissue for mechanical function and by type II collagen immunohistochemistry. We demonstrate selective seeding of viable MSCs within the channels. MSC aligned and produced mature collagen fibrils along the length of the channel in smaller linear channels of widths 25–100 μm compared to larger linear channels of widths 500–1000 μm. Further, substrates with microchannels that led to cell alignment also led to superior mechanical properties compared to constructs with randomly seeded cells or selectively seeded cells in larger channels. The ultimate stress and modulus of elasticity of constructs with cells seeded in smaller channels increased by as much as fourfolds. We conclude that microscale guidance is useful to produce oriented cartilage structures with improved mechanical properties. These findings can be used to fabricate large clinically useful MSC–cartilage constructs with superior mechanical properties.

20 December 2021 in Bioactive Materials
Verified
Journal Article
Open access
KGKihak Gwon
Kihak Gwon
HHHye Jin Hong
Hye Jin Hong
Alan M Gonzalez-SuarezAlan M Gonzalez-Suarez
Alan M Gonzalez-Suarez
MSMichael Q. Slama
Michael Q. Slama
DCDaheui Choi
Daheui Choi
ARAlexander Revzin
Alexander Revzin
Human pluripotent stem cells (hPSC) hold considerable promise as a source of adult cells for treatment of diseases ranging from diabetes to liver failure. Some of the challenges that limit the clinical/translational impact of hPSCs are high cost and difficulty in scaling-up of existing differentiation protocols. In this paper, we sought to address these challenges through the development of bioactive microcapsules. A co-axial flow focusing microfluidic device was used to encapsulate hPSCs in microcapsules comprised of an aqueous core and a hydrogel shell. Importantly, the shell contained heparin moieties for growth factor (GF) binding and release. The aqueous core enabled rapid aggregation of hPSCs into 3D spheroids while the bioactive hydrogel shell was used to load inductive cues driving pluripotency maintenance and endodermal differentiation. Specifically, we demonstrated that one-time, 1 h long loading of pluripotency signals, fibroblast growth factor (FGF)-2 and transforming growth factor (TGF)-β1, into bioactive microcapsules was sufficient to induce and maintain pluripotency of hPSCs over the course of 5 days at levels similar to or better than a standard protocol with soluble GFs. Furthermore, stem cell-carrying microcapsules that previously contained pluripotency signals could be reloaded with an endodermal cue, Nodal, resulting in higher levels of endodermal markers compared to stem cells differentiated in a standard protocol. Overall, bioactive heparin-containing core-shell microcapsules decreased GF usage five-fold while improving stem cell phenotype and are well suited for 3D cultivation of hPSCs.